Shawn Tinlin

1.3k total citations
18 papers, 953 citations indexed

About

Shawn Tinlin is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Shawn Tinlin has authored 18 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Shawn Tinlin's work include Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Shawn Tinlin is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Hemophilia Treatment and Research (9 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Shawn Tinlin collaborates with scholars based in Canada. Shawn Tinlin's co-authors include Colleen Notley, David Lillicrap, Christine Hough, Alan R. Giles, Megan E. Begbie, Jayne Leggo, Carol Hegadorn, Angie Tuttle, Lee A. O’Brien and D Lillicrap and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

Shawn Tinlin

18 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn Tinlin Canada 15 655 329 266 167 103 18 953
Colleen Notley Canada 22 1.1k 1.7× 368 1.1× 316 1.2× 162 1.0× 177 1.7× 39 1.5k
Bella Madan United Kingdom 10 562 0.9× 547 1.7× 486 1.8× 384 2.3× 54 0.5× 12 1.3k
M. Bérard France 15 225 0.3× 80 0.2× 105 0.4× 65 0.4× 87 0.8× 34 586
JL McGregor France 10 353 0.5× 55 0.2× 110 0.4× 75 0.4× 71 0.7× 15 616
SA Burstein United States 11 398 0.6× 31 0.1× 125 0.5× 106 0.6× 53 0.5× 20 575
Halina Leung Australia 10 189 0.3× 54 0.2× 189 0.7× 37 0.2× 137 1.3× 14 608
Daniel El Fassi Denmark 14 173 0.3× 85 0.3× 131 0.5× 37 0.2× 61 0.6× 36 725
Walter Kisiel United States 11 397 0.6× 28 0.1× 171 0.6× 90 0.5× 54 0.5× 12 635
L. E. Silberstein United States 13 265 0.4× 49 0.1× 115 0.4× 52 0.3× 46 0.4× 21 631
Marie J. Desierto United States 13 681 1.0× 91 0.3× 158 0.6× 143 0.9× 34 0.3× 25 937

Countries citing papers authored by Shawn Tinlin

Since Specialization
Citations

This map shows the geographic impact of Shawn Tinlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn Tinlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn Tinlin more than expected).

Fields of papers citing papers by Shawn Tinlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn Tinlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn Tinlin. The network helps show where Shawn Tinlin may publish in the future.

Co-authorship network of co-authors of Shawn Tinlin

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn Tinlin. A scholar is included among the top collaborators of Shawn Tinlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn Tinlin. Shawn Tinlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bowman, Mackenzie, Angie Tuttle, Colleen Notley, et al.. (2013). The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles. Journal of Thrombosis and Haemostasis. 11(3). 512–520. 55 indexed citations
2.
James, Paula D., Colleen Notley, Carol Hegadorn, et al.. (2006). The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood. 109(1). 145–154. 224 indexed citations
3.
James, Paula, Andrew D. Paterson, Colleen Notley, et al.. (2006). Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study. Journal of Thrombosis and Haemostasis. 4(4). 783–792. 58 indexed citations
4.
Brown, Brian D., et al.. (2004). Factors influencing therapeutic efficacy and the host immune response to helper‐dependent adenoviral gene therapy in hemophilia A mice. Journal of Thrombosis and Haemostasis. 2(1). 111–118. 44 indexed citations
5.
Chang, Shi, Brian D. Brown, Shawn Tinlin, et al.. (2004). Heterogeneity of the immune response to adenovirus‐mediated factor VIII gene therapy in different inbred hemophilic mouse strains. The Journal of Gene Medicine. 6(12). 1358–1368. 25 indexed citations
6.
Brown, Brian D., Shawn Tinlin, M Shaw, et al.. (2003). The use of three hemophilia A mouse models to illustrate strain-specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy. Journal of Thrombosis and Haemostasis. 1. P0041–P0041. 1 indexed citations
7.
Scallan, Ciaran D., David Lillicrap, Haiyan Jiang, et al.. (2003). Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector. Blood. 102(6). 2031–2037. 82 indexed citations
8.
Hough, Christine, Seiki Kamisue, Cherie Cameron, et al.. (2002). Aberrant Splicing and Premature Termination of Transcription of the FVIII Gene as a Cause of Severe Canine Hemophilia A: Similarities with the Intron 22 Inversion Mutation in Human Hemophilia. Thrombosis and Haemostasis. 87(4). 659–665. 66 indexed citations
10.
Notley, Colleen, et al.. (2000). The Factor VIII Acute Phase Response Requires the Participation of NFκB and C/EBP. Thrombosis and Haemostasis. 84(8). 216–222. 61 indexed citations
11.
Begbie, Megan E., et al.. (2000). The Factor VIII acute phase response requires the participation of NFkappaB and C/EBP.. PubMed. 84(2). 216–22. 90 indexed citations
12.
Senis, Yotis A., Mary Richardson, Shawn Tinlin, Donald H. Maurice, & Alan R. Giles. (1996). Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo. British Journal of Haematology. 93(1). 195–203. 30 indexed citations
13.
Richardson, Mary, et al.. (1994). Morphological alterations in endothelial cells associated with the release of von Willebrand factor after thrombin generation in vivo.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(6). 990–999. 20 indexed citations
14.
Tinlin, Shawn, et al.. (1993). The Development of Homologous (Canine/Anti-Canine) Antibodies in Dogs with Haemophilia A (Factor VIII Deficiency): A Ten-Year Longitudinal Study. Thrombosis and Haemostasis. 69(1). 21–24. 30 indexed citations
15.
Giles, AR, et al.. (1988). In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency). Blood. 72(1). 335–339. 36 indexed citations
16.
Giles, AR, et al.. (1988). In vivo characterization of recombinant factor VIII in a canine model of hemophilia A (factor VIII deficiency). Blood. 72(1). 335–339. 4 indexed citations
17.
Giles, Alan R., H Hoogendoorn, & Shawn Tinlin. (1984). The thrombogenicity of prothrombin complex concentrates. IV. The source of coagulant-active phospholipid. Thrombosis Research. 34(6). 567–572. 4 indexed citations
18.
Giles, AR, et al.. (1984). Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency). Blood. 63(2). 451–456. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026